2023-04-13 10:37
(435 d 14:54 ago)

Posting: # 23523
Views: 1,253

 FDA draft guidance on transdermal systems [BE/BA News]

Dear all,

If you're working on transdermal and topical delivery systems, you will be interested in two new FDA draft guidance documents:
- one on the assessment of irritation and sensitisation potential;
- one on the assessment of adhesion.

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,663 registered users;
41 visitors (0 registered, 41 guests [including 7 identified bots]).
Forum time: 01:31 CEST (Europe/Vienna)

[…] an inappropriate study design is incapable of answering
a research question, no matter how careful the subsequent
methodology, conduct, analysis, and interpretation:
Flawless execution of a flawed design achieves nothing worthwhile.    J. Rick Turner

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz